The nation of Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) spanning five years due to the United States' request for sensitive data.
This rejection became public following a government memo dated December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "lopsided".
A government representative later explained that the US was requesting biological samples for scientific study and profit while refused to guarantee the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more talks to secure a agreement suitable to both sides so the country's critical HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision follows a similar case in Kenya, where a high court suspended a similar deal with the US after concerns were filed about the safety of citizens' health data.
After returning to office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
As per statements, 16 nations in Africa have so far signed these new health pacts, representing more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no corresponding promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"In essence, our country would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our people if a new health crisis emerge."
Sovereignty and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks previously established through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.
"This mechanism is intended to ensure that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage continued discussions with our American counterparts on how future collaboration might be arranged in a way that honours the independence and dignity of each country."
Health Experts Response
Medical experts said it recognised the official position, but recommended that negotiations need to persist given that a large portion of the country's Aids initiatives were funded by external financing.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," it added.
The halted deal underscores the ongoing challenges between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.